They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.